References
- Fukushige J, Takahashi N, Ueda Y, Ueda K. Incidence and clinical features of incomplete Kawasaki disease. Acta Paediatr 1994;83:1057-60. https://doi.org/10.1111/j.1651-2227.1994.tb12985.x
- Joffe A, Kabani A, Jadavji T. Atypical and complicated Kawasaki disease in infants: do we need criteria? West J Med 1995;162:322-7.
- Anne HR, Stanford TS. Kawasaki syndrome. Pediatr Clin North Am 1999;46:313-29. https://doi.org/10.1016/S0031-3955(05)70120-6
- Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Pediatrics 2004;114:1708- 33. https://doi.org/10.1542/peds.2004-2182
- Cowie M, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, et al. Clinical applications of B-type natriuretic peptide(BNP) testing. Eur Heart J 2003;24:1710-8. https://doi.org/10.1016/S0195-668X(03)00476-7
- Saenger AK, Jaffe AS. The use of biomarkers for the evaluation and treatment of patients with acute coronary syndromes. Med Clin North Am 2007;91:657-81. https://doi.org/10.1016/j.mcna.2007.04.001
- Cowie M, Mendez G. BNP and congestive heart failure. Prog Cardiovasc Dis 2002;44:293-321. https://doi.org/10.1053/pcad.2002.24599
- Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993;88:82-91. https://doi.org/10.1161/01.CIR.88.1.82
- Fried I, Bar-Oz B, Perles Z, Rein AJ, Zonis Z, Nir A. Nterminal Pro-B-type natriuretic peptide levels in acute versus chronic left ventricular dysfunction. J Pediatr 2006;149:28-31. https://doi.org/10.1016/j.jpeds.2006.02.038
- Nir A, Lindinger A, Rauh M, Bar-Oz B, Laer S, Schwachtgen L, et al. NT-Pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol 2009;30:3-8. https://doi.org/10.1007/s00246-008-9258-4
- Reynolds EW, Ellington JG, Vranicar M, Bada HS. Brain type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatrics 2004;114:1297-304. https://doi.org/10.1542/peds.2004-0525
- Ohuchi H, Takasugi H, Ohashi H, Okada Y, Yamada O, Ono Y, et al. Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease. Circulation 2003; 108:2368–76.
- Kawamura T, Wago M, Kawaguchi H, Tahara M, Yuge M. Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int 2000;42:241-8. https://doi.org/10.1046/j.1442-200x.2000.01225.x
- Lee HJ, Kim HJ, Kim HS, Sohn SJ. NT-pro BNP: A new diagnostic screening tool for Kawasaki disease. Korean J Pediatr 2006;49:539-44. https://doi.org/10.3345/kjp.2006.49.5.539
- Dahdah N, Siles A, Fournier A, Cousineau J, Delvin E, Saint- Cyr C, et al. Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr Cardiol 2009;30:810-7. https://doi.org/10.1007/s00246-009-9441-2
- Heo MY, Choi SJ, Kim HS, Sohn SJ. Clinical features of aty pical Kawasaki disease. J Korean Pediatr Soc 2002;45:376-82..
- Yu YI, Kim DJ, Yum MK, Kim Ns, Lee HB. Clinical study of typical and atypical Kawasaki diseases. J Korean Pediatr Soc 1998;41:237-46.
- Kalra PR, Anker SD, Coats AJ. Water and sodium regulation in chronic heart failure : the role of natriuretic peptides and vasopressin. Cardiovasc Res 2001;51:495-509. https://doi.org/10.1016/S0008-6363(01)00297-8
- Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K, Suga S, et al. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 1990;323:757-8. https://doi.org/10.1056/NEJM199009133231114
- Uusimaa P, Ruskoaho H, Vuolteenaho O, Niemelä M, Lumme J, Ikäheimo M, et al. Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction. Int J Cardiol 1999;69:5–14. https://doi.org/10.1016/S0167-5273(99)00007-8
- Masson S, Latini R. Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure. Am J Cardiol 2008;101:56-60. https://doi.org/10.1016/j.amjcard.2007.11.024
- Omland T, Persson A, Ng L, O'Brien R, Karlsson T, Herlitz J, et al. N-terminal pro-B-type natriuretic peptide and longterm mortality in acute coronary syndromes. Circulation 2002; 106:2913-8. https://doi.org/10.1161/01.CIR.0000041661.63285.AE
- Bionda C, Bergerot C, Ardail D, Rodriguez-Lafrasse C, Rousson R. Plasma BNP and NT-proBNP assays by automated immunoanalyzers: analytical and clinical study. Ann Clin Lab Sci 2006;36:299–306.
- Suda K, Matsumura M, Matsumoto M. Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int 2003;45:249–54. https://doi.org/10.1046/j.1442-200X.2003.01716.x
- Law YM, Ettedgui J, Beerman L, Maisel A, Tofovic S. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure. Am J Cardiol 2006;98:520-4. https://doi.org/10.1016/j.amjcard.2006.02.058
- Price JF, Thomas AK, Grenier M, Eidem BW, O'Brian Smith E, Denfield SW. et al. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation 2006; 114:1063–9. https://doi.org/10.1161/CIRCULATIONAHA.105.608869
- Nir A, Lindinger A, Rauh M, Bar-Oz B, Laer S, Schwachtgen L, et al. NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol 2009;30:3-8. https://doi.org/10.1007/s00246-008-9258-4
Cited by
- N-terminal Pro-Brain Natriuretic Peptide (NT proBNP) as a Predictive Indicator of Initial Intravenous Immunoglobulin Treatment Failure in Children With Kawasaki Disease: A Retrospective Study vol.34, pp.8, 2010, https://doi.org/10.1007/s00246-013-0724-2
- N-terminal pro-brain natriuretic peptide in acute Kawasaki disease correlates with coronary artery involvement vol.25, pp.7, 2010, https://doi.org/10.1017/s1047951114002431
- Usefulness of Age-Stratified N-Terminal Prohormone of Brain Natriuretic Peptide for Diagnosing Kawasaki Disease vol.2017, pp.None, 2010, https://doi.org/10.1155/2017/6263121
- N-terminal probrain natriuretic peptide as biomarker for diagnosis of Kawasaki disease vol.13, pp.4, 2010, https://doi.org/10.2217/bmm-2018-0324
- Serum Ferritin as a Diagnostic Biomarker for Kawasaki Disease vol.41, pp.3, 2010, https://doi.org/10.3343/alm.2021.41.3.318